1. Home
  2. EVO vs RPD Comparison

EVO vs RPD Comparison

Compare EVO & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • RPD
  • Stock Information
  • Founded
  • EVO 1993
  • RPD 2000
  • Country
  • EVO Germany
  • RPD United States
  • Employees
  • EVO N/A
  • RPD N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • RPD Computer Software: Prepackaged Software
  • Sector
  • EVO Health Care
  • RPD Technology
  • Exchange
  • EVO Nasdaq
  • RPD Nasdaq
  • Market Cap
  • EVO 1.2B
  • RPD 1.3B
  • IPO Year
  • EVO 2021
  • RPD 2015
  • Fundamental
  • Price
  • EVO $3.48
  • RPD $20.35
  • Analyst Decision
  • EVO Buy
  • RPD Hold
  • Analyst Count
  • EVO 2
  • RPD 19
  • Target Price
  • EVO $5.40
  • RPD $27.00
  • AVG Volume (30 Days)
  • EVO 52.1K
  • RPD 950.8K
  • Earning Date
  • EVO 11-05-2025
  • RPD 11-05-2025
  • Dividend Yield
  • EVO N/A
  • RPD N/A
  • EPS Growth
  • EVO N/A
  • RPD N/A
  • EPS
  • EVO N/A
  • RPD 0.43
  • Revenue
  • EVO $912,894,891.00
  • RPD $855,361,000.00
  • Revenue This Year
  • EVO $0.43
  • RPD $2.75
  • Revenue Next Year
  • EVO $9.72
  • RPD $3.32
  • P/E Ratio
  • EVO N/A
  • RPD $47.09
  • Revenue Growth
  • EVO N/A
  • RPD 4.67
  • 52 Week Low
  • EVO $2.84
  • RPD $17.83
  • 52 Week High
  • EVO $5.64
  • RPD $44.48
  • Technical
  • Relative Strength Index (RSI)
  • EVO 39.62
  • RPD 46.48
  • Support Level
  • EVO $3.36
  • RPD $19.57
  • Resistance Level
  • EVO $3.52
  • RPD $20.62
  • Average True Range (ATR)
  • EVO 0.08
  • RPD 0.66
  • MACD
  • EVO 0.00
  • RPD 0.06
  • Stochastic Oscillator
  • EVO 31.58
  • RPD 35.37

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About RPD Rapid7 Inc.

Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.

Share on Social Networks: